ES421726A1 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ES421726A1
ES421726A1 ES421726A ES421726A ES421726A1 ES 421726 A1 ES421726 A1 ES 421726A1 ES 421726 A ES421726 A ES 421726A ES 421726 A ES421726 A ES 421726A ES 421726 A1 ES421726 A1 ES 421726A1
Authority
ES
Spain
Prior art keywords
group
substituted
choice
groups
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES421726A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES421726A1 publication Critical patent/ES421726A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Procedure for preparing derivatives of 6-substituted-aminopenicyllanic and 7-substituted-aminocephalosporanic acids, with the general formulas **(See formula)** where U represents an amido group (eg saccharyl, succinimido or phthalamido) or a group OE' where E' represents hydrogen, a salt-forming cation, a steric residue such as a (lower) alkyl group substituted by choice with a (lower) alkanoyloxy group which can also be substituted, a silyl group, a phenacyl group, a benzyl group, a benzohydryl group, a trichlorethyl group, or tert-butyl, X represents a hydrogen atom, a hydroxy group, a (lower) alkanoyloxy group (preferably acetoxy) or the residue of a nucleophilic agent, such as a halogen atom, an acid group, a cyano group, and carbamoyloxy group, a choice substituted heterocyclic mononuclear group containing an atom of sulfur or nitrogen (eg pyridinyl); an -S-Q' group (where Q' represents a diazolyl, triazolyl, tetrazolyl, thiazolyl, thiadiazolyl, triatriazolyl, oxazolyl, oxadiazolyl, benzimidazolyl, benzoxazolyl, triazol-pyridinyl or puridinyl group), or X represents an amino group where Q represents a group with the formula XX; R1 represents a lower alkyl group (eg methyl, ethyl, propyl, isopropyl, butyl, sec.butyl, isobutyl, t-butyl) optionally substituted in primary or secondary position with 1 fluorine, chlorine atom, a group hydroxy, or lower alkoxy (eg fluoromethyl, 2-chloroethyl, methoxymethyl, 1-hydroxyethyl) or a cycloalkyl group optionally substituted with 1 or more lower alkyl groups, hydroxy or lower alkoxy groups or where R1 represents an adamantyl group or a phenyl group substituted by choice with a maximum of 3 of the substituents selected from chlorine, fluorine, hydroxy, lower alkoxy and lower alkyl, or where it represents a five-membered mononuclear heterocyclic group ( for example, furyl, thienyl, isoxazolyl, isothiazolyl, oxadiazolyl) substituted by choice with lower alkyl groups, or where R1 represents an aralkyl group (for example, benzyl) substituted by choice in the phenyl nucleus as mentioned above, or a carboxymethyl group, and Z1 '' represents, together with the definition indicated above for R1, a hydrogen atom, a (lower) alkyl group optionally substituted with a chlorine or fluorine atom, a (lower) alkoxy group, a cycloalkyl group, a phenyl group, which in turn is substituted by choice with a maximum of three of the aforementioned substituents, or Z1'' represents a carboxy group esterified with a residue of (lower) alkyl, phenyl, cycloalkyl or aralkyl, being at choice said phenyl radicals substituted with a maximum of one of the aforementioned substituents, or Z1'' represents a carbamoyl group N-substituted at choice with one or two lower alkyl groups, a phenyl group, a mononuclear heterocyclic group of five members, one cycloalkyl group, one or two arylalkyl (lower) or cycloalkylalkyl groups (lower being the phenyl and cycloalkyl groups substituted by choice with a maximum of one of the sub above, or Z1'' represents a carbamoyl group having its nitrogen atom as a member of a heterocyclic ring (eg, morpholino) and where R2 represents a group **(See formula)** where n represents 0, 1, 2 or 3, and R3 represents a hydrogen atom or a (lower) alkyl group, and R4 represents a hydrogen atom, a (lower) alkyl, a cycloalkyl, phenyl or aralkyl group, or R4 represents a -COOE group, where E represents a hydrogen atom or a salt-forming group (when n>> 1), or a (lower) alkyl, benzyl or phenyl ester residue, or represents a carbamoyl group N - substituted by choice with one or two (lower) or alkenyl groups, a phenyl group, a cycloalkyl group, one or two arylalkyl (lower) or cycloalkylalkyl (lower) groups, with the phenyl and cycloalkyl groups being substituted with a maximum of one of the aforementioned substituents, or where R3 and R4, together with the carbon atom to which they are attached, represent a substituted cycloalkyl group of choice, and Z4 represents a hydrogen atom or a substituted aryl group of choice which comprises making react a salt, this er or amide of the compound of 6-aminopenicillanic or 7- aminocephalosporic acid of the formulas **(See formula)** where X represents a hydrogen atom, a hydroxy group, a lower alkanoyloxy group (preferably acetoxy) or the residue of a nucleophilic agent, such as a halogen atom, an acid group, a cyano group, a carbamoyloxy group, a Mononuclear heterocyclic group substituted by choice containing a sulfur or nitrogen atom (for example pyridinyl); a -SQ'group (where Q' represents a diazolyl, triazolyl, tetrazolyl, thiazolyl, thiadiazolyl, thiatriazolyl, oxazolyl, oxadiazolyl, benzimidazolyl, benzoxazolyl, triazolpyridinyl or purinyl group, optionally substituted) or X represents an amino group when Q represents a group of the formula XX, with the substituent X when it is a hydroxy group or a preferably protected amino group, with an active ester, acid halide, acid anhydride, including a mixed anhydride prepared from stronger acids, acidic acid, active thioester or azolide derived from an acid of the general formula **(See formula)** where (see formula) are as previously defined for R1 and Z1'' or represent groups that can easily become those that fall within the definition of R1 and Z'' and that can be influenced or can react equally under the conditions of reaction used (for example) hydroxy and carboxy protected amino groups) or **(See formula)** where (see formula) are as previously defined for R2 and Z4 or represent groups that can easily become those that fall within the definition of R2 and Z4 or with the acid of formulas XXX or XXXI on their own in the presence of per example a carbodiimide reagent or the like; followed by separation and isolation, or both, of the obtained compound and the removal of the protecting groups present at choice in order to form the corresponding penicilllanic or cephalosporanic acids, and the transformation at choice of these obtained acids into their salts or esters. (Machine-translation by Google Translate, not legally binding)
ES421726A 1972-12-22 1973-12-21 Heterocyclic compounds Expired ES421726A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5952472A GB1459392A (en) 1972-12-22 1972-12-22 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ES421726A1 true ES421726A1 (en) 1976-04-16

Family

ID=10483917

Family Applications (3)

Application Number Title Priority Date Filing Date
ES421726A Expired ES421726A1 (en) 1972-12-22 1973-12-21 Heterocyclic compounds
ES423962A Expired ES423962A1 (en) 1972-12-22 1974-03-06 Heterocyclic compounds
ES423963A Expired ES423963A1 (en) 1972-12-22 1974-03-06 Heterocyclic compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES423962A Expired ES423962A1 (en) 1972-12-22 1974-03-06 Heterocyclic compounds
ES423963A Expired ES423963A1 (en) 1972-12-22 1974-03-06 Heterocyclic compounds

Country Status (10)

Country Link
JP (3) JPS4994695A (en)
AT (1) AT344318B (en)
BE (1) BE809037A (en)
DE (2) DE2364129A1 (en)
ES (3) ES421726A1 (en)
FR (2) FR2211232B1 (en)
GB (1) GB1459392A (en)
HU (1) HU167924B (en)
NL (2) NL162654C (en)
SE (3) SE7611135L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905893A (en) * 1973-08-22 1975-09-16 Gulf Research Development Co Plural stage residue hydrodesulfurization process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1364453A (en) * 1970-11-06 1974-08-21 Gist Brocades Nv Penicillanic and cepholosporanic acid derivatives

Also Published As

Publication number Publication date
ATA1072573A (en) 1977-11-15
AT344318B (en) 1978-07-10
BE809037A (en) 1974-06-21
DE2365705A1 (en) 1976-01-15
JPS4994695A (en) 1974-09-09
SE7905814L (en) 1979-07-03
FR2289171A1 (en) 1976-05-28
GB1459392A (en) 1976-12-22
NL162654C (en) 1980-06-16
FR2211232B1 (en) 1978-01-13
DE2364129A1 (en) 1974-07-25
NL7807076A (en) 1978-10-31
HU167924B (en) 1976-01-28
NL7317432A (en) 1974-06-25
ES423963A1 (en) 1976-07-01
JPS5373565A (en) 1978-06-30
SE7611135L (en) 1976-10-07
SE7611134L (en) 1976-10-07
NL162654B (en) 1980-01-15
ES423962A1 (en) 1976-07-01
FR2211232A1 (en) 1974-07-19
JPS5377088A (en) 1978-07-08

Similar Documents

Publication Publication Date Title
ES8607244A1 (en) Use of quinoline derivatives for the protection of cultivated plants.
PT76316A (en) Process for the preparation of esters of substituted pyridino- 3,5-dicarboxylic and/or of pyrano-3,5-dicarboxylic acids having an hypotensive effect and application thereof for the preparation of pharmaceutical compositions having an hypotensive effect
NL7505375A (en) NEW PENICILLIN AND CEPHALOSPORIN DERIVATIVES AND METHOD FOR PREPARING THEM.
IE45015L (en) Cephalosporin derivatives.
DK0620225T3 (en) cephalosporin
GB1064252A (en) Amides and pharmaceutical compositions containing them
ES8200685A1 (en) 3-optionally substituted methyl-2- penem derivatives
GB1053085A (en)
GB1459065A (en) Therapeutic thiophene derivatives
GB1505885A (en) Substituted cephalosporins
ES421726A1 (en) Heterocyclic compounds
ES479570A1 (en) 7 alpha -Methoxycephalosporin derivatives and their pharmaceutical compositions having antibacterial activity
IE41219L (en) Aralkyl esters of aminoalkanoic acids
ES478387A1 (en) Beta-lactam compounds, process for their preparation and their use in medicines.
ATE123487T1 (en) DERIVATIVES OF CAFEIC ACID AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES469182A1 (en) Antibacterial agents
JPS5246093A (en) 2-alkyl-7-substituted-2, or 3-cephem-4-carboxylic compounds, their sal ts, and preparation thereof
GB1321407A (en) 1-phenyl-4-amino-cyclohex-2-ene-1-carboxylic acid esters
ES484115A1 (en) Aurone derivatives
ZA857945B (en) 4-hydroxy-3-quinoline carboxylic acid derivatives substituted at position 2 by an alpha-hydroxylated chain,process for their preparation,their use as medicaments and compositions containing them
JPS54106495A (en) Cephem derivative
GB1410852A (en) Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them
AU4878479A (en) Clavulanic acid derivatives
ES430905A1 (en) Tetrazole coumarin derivatives
KR850000456A (en) Process for preparing cephalosporin ester